Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran
Abstract
Background and Objectives: Urinary tract infection (UTI) is one of the most common infections in the world. The majority of UTIs are caused by Uropathogenic Escherichia coli (UPEC) strains. FimH and FliC are the most important virulence factors of UPEC. To date, any ideal vaccine against UTI has not been approved for human use and we need to test new targets to develop an ideal vaccine against UTI. In this study, we constructed fusion fimH/fliC of UPEC as a novel vaccine candidate against UTI.
Material and Methods: PCR amplification of fimH and fliC genes of the UPEC isolates was performed by specific primers designed for this purpose. Construction of fimH/fliC hybrid gene was performed by overlap PCR. The fimH, fliC and fimH/ fliC were cloned in pET28a vector. The confirmation of expression of the proteins was done by SDS-PAGE and Western blot.
Results: The fliC and fimH genes were amplified in all of the UPEC isolates tested. The fimH showed significant homology with the sequences in GenBank. We generated a fusion consisting of the fimH linked to the N-terminal end of fliC. Sequencing of the fusion fimH/fliC showed that fusion was constructed correctly. SDS-PAGE and western blot confirmed the expression of the proteins in optimized condition.
Conclusion: Urinary tract infection is a huge burden on healthcare system in many countries. UPEC is isolated in around 80% of UTI cases. Antibiotic therapy resulted in the emergence of antibiotic resistance in UPEC strains. This is the major cause for an increasing requirement for a vaccine to prevent UTI. This work describes for the first time the construction of a novel fusion protein from Iranian UPEC isolates. Further immunological studies are required for evaluation of this protein as a novel and safe vaccine candidate against UTI caused by UPEC.
Ragnarsdottir B, Fischer H, Godaly G, Gronberg- Hernandez J, Gustafsson M, Karpman D, et al. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest 2008; 38 (S2): 12-20.
Dhakal BK, Kulesus RR, Mulvey MA. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 2008; 38 (S2): 2-11.
Langermann S, Mollby R, Burlein JE, Palazynski SR, Auguste CG, DeFusco A, et al. Vaccination with FimH adhesion protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 2000; 181: 774-778.
Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. Int J Infect Dis 2009; 13: 140-144.
Lahsaeizadeh S, Jafari H, Askarian M. Healthcare- associated infection in Shiraz, Iran 2004-2005. J Hospital Infect 2008; 69: 283-287.
Kashef N, Esmaeeli Djavid G, Shahbazi S. Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran, Iran. J Infect Dev Ctries 2010;4(4): 202-206.
Ghorashi Z, Ghorashi S, Soltani-Ahari H, Nezami N.Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran. Infect and Drug Resist 2011; 4: 171-176.
Wright KJ, Seed PC, Hultgren SJ. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun 2005; 73: 7657- 7668.
Lane MC, Alteri CJ, Smith SN, Mobley HLT. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. PNAS 2007;104: 16669-16674.
Welch RA, Burland V, Plunkett G, Redford P, Roesch P, Rasko D, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. PNAS 2002; 99: 17020-17024.
Tiba MR, Yano T, Leite DDS. Genotypic characterization of virulence factors in Escherichia coli strains from patients with cystitis. Rev Inst Med Trop 2008; 50(5):255-260.
Langermann S, Ballou WR. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis 2001; 183: S84-86.immune system. Immun Lett 2005; 101: 117-122.
Salazar-Gonzalez RM, McSorley SJ.Salmonella like chaperone that directs assembly of type 1 pili in flagellin. a microbial target of the innate and adaptive bacteria. Proc Natl Acad Sci 1993; 90: 8397-8401.
Schwan WR. Flagella allow uropathogenic Escherichia coli ascension into murine kidneys. Int J Med Microbiol 2008; 298: 441-447.
Smith KD, Anderson-Nissen E, Hayashi F, Strobe K, Bergman MA, Rassoulian Barret SL, et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nature Immun 2003; 4: 1247-1253.
Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis 2009; 200: 263-272.
Yousefi Mashouf R, Babalhavaeji H, Yousef J. Urinary tract infection: bacteriology and antibiotic resistance patterns. Indian Pediatrics 2009; 15: 1-4.
Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-272.
Francis DM, Page R. Strategies to optimize protein expression in E.coli. Curr Protocol Protein Sci 2010;61: 1-29.
Sorensen HP, Mortensen KK. Advanced genetic strateg- ies for recombinant protein expression in Escherichia coli. J Biotech 2005; 115: 113-128.
Baneyx F. Recombinant protein expression in Escherichia coli. Curr Opinion Biotech 1999; 10: 411-421.
Vetsch M, Sebbel P, Glockshuber R. Chaperon- independent folding of type 1 pilus domains. J Mol Biol 2002; 322: 827-840.
Jones CH, Pinkner JS, Nicholes AV, Slonim LN, Abraham SN, Hultgren SJ. FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria. Proc Natl Acad Sci 1993; 90: 8397-8401.
| Files | ||
| Issue | Vol 4 No 2 (2012) | |
| Section | Articles | |
| Keywords | ||
| Uropathogenic Escherichia coli fimH fliC fusion protein expression urinary tract infection | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
